佛燃能源(002911.SZ):完成兑付本息2.06億元中期票據
格隆匯3月6日丨佛燃能源(002911.SZ)公吿稱公司於2020年3月4日發行了2020年度第一期中期票據,發行總額為人民幣2億元,發行利率為3.1%,發行期限為3+2年(第三個計息年度末附設發行人票面利率調整選擇權和投資者回售選擇權),起息日為2020年3月6日,兑付日為2025年3月6日(如投資人行使回售選擇權,則其回售部分本期中期票據的兑付日為2023年3月6日)。
近日,公司已完成該期中期票據的投資者回售登記,回售金額為人民幣2億元;截至該公吿披露日,公司完成了該期中期票據的兑付,本息合計人民幣2.062億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.